HCAP Partners Invests in Real Diagnostics for Growth Expansion
HCAP Partners has announced its investment in Real Diagnostics, a clinical laboratory specializing in rapid and accurate testing, announced in a press release. This investment supports Salt Creek Capital's acquisition of RealDx and aims to expand access to high-quality diagnostic services.
RealDx provides diagnostic services across 17 states, offering test results within 24 hours and leveraging proprietary technology to enhance diagnostic accuracy. The company serves physician offices, specialty clinics, and skilled nursing facilities, distinguishing itself with its rapid and precise testing capabilities.
Cary Breese, the incoming CEO of RealDx, brings over 20 years of experience in healthcare and technology, having previously co-founded NowRx. With the support of Salt Creek Capital and HCAP Partners, RealDx is poised to expand its reach and continue delivering timely, accurate diagnostics to improve patient care.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 Truven launches MarketScan Snapshot for healthcare data checks Sep 29 Omega Healthcare Wins Gold in 2026 AI Breakthrough Awards Sep 29 Phylo Launches Target Atlas for Drug Target Prioritization Sep 29 ChromAgeNet Detects Aging Signs in Blood Stem Cell Images Sep 29 Axxess Partners With Eazewell for Hospice Family SupportLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Healthcare Triangle Joins Kanzun-ARCB Fund to Connect Malaysian Companies With US Capital
Probably Genetic Gets Up to $10M ARPA-H Contract for Rare Disease AI
Deep Longevity to Launch Accrua Telehealth Platform in US
I-care Acquires Amiral Technologies for Predictive Maintenance AI
Daily AI Brief: the AI news that matters, in your inbox.